References

Al Wattar BH, Talaulikar V Non-oestrogen-based and complementary therapies for menopause. Best Pract Res Clin Endocrinol Metab. 2024; 38:(1) https://doi.org/10.1016/j.beem.2023.101819

Cardwell CR, Ranger TA, Labeit AM, Coupland CAC, Hicks B, Hughes C, McMenamin Ú, Mei XW, Murchie P, Hippisley-Cox J Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records. Br J Cancer. 2024; 131:(4)737-746 https://doi.org/10.1038/s41416-024-02767-8

Mansour D, Barber K, Chalk G, Noble N, Digpal AAS, Talaulikar V, Gray S The evolving perspective of menopause management in the United Kingdom. Womens Health (Lond). 2024; 20 https://doi.org/10.1177/17455057241288641

National Institute for Health and Care Excellence. Menopause: diagnosis and management. 2019. https://www.nice.org.uk/guidance/ng23/resources/menopause-diagnosis-and-management-pdf (accessed 27 November 2024)

Rossouw JE, Anderson GL, Prentice RL Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288:(3)321-33 https://doi.org/10.1001/jama.288.3.321

Prescribing in menopause care

02 December 2024
Volume 6 · Issue 12

Abstract

Deborah Robertson provides an overview of recently published articles that may be of interest to non-medical prescribers. Should you wish to look at any of the papers in more detail, a full reference is provided

Last month, the research round-up provided you with an overview of articles looking at prescribing in frailty. This month, we will look at a range of articles around management of the menopause. The first article examines the evolution of menopausal management in the UK and changes over the last decade. The second article explores the use of non-oestrogen therapies and complementary and alternative approaches in management of menopausal symptoms. Finally, in our third article we will review a study into the impact of hormone replacement therapy (HRT) and cancer outcomes.

This article, published in the journal Women's Health, sought to evaluate the factors contributing to the apparent change in the perceptions of women and health professionals of the use of menopausal hormone therapy (MHT) in the UK. The aim was to review changes in the last decade that reversed the decline in the use of MHT after the publication of the Women's Health Initiative Study in 2002, which suggested an increase in breast cancer and heart disease associated with MHT (Rossouw et al, 2002).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month